TVTX Travere Therapeutics, Inc.
Nasdaq · SEC CIK 1438533 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $104.24M 61 sales by 11 insiders
- Filings on record
- 233 since 2021-07-29, latest 2026-09-17 21:35
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Dube Eric M | CEO, Dir | — | $41.35M |
| Heerma Peter | EVP, Chief COMMERCIAL Off | — | $18.97M |
| ROTE WILLIAM E. | Chief Research Off | — | $16.43M |
| REED ELIZABETH E | CLO, GC | — | $7.02M |
| Inrig Jula | EVP, CMO, Head of R, D | — | $5.16M |
| Cline Christopher R. | CFO | — | $4.64M |
| Calvin Sandra | SVP, CAO | — | $4.19M |
| Baynes Roy D. | Dir | — | $2.55M |
| Meckler Jeffrey A | Dir | — | $1.71M |
| Coughlin Timothy | Dir | — | $1.27M |
Transactions 348
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-09-17 21:35 | 2026-09-15+ | TVTX | ROTE WILLIAM E. | Chief Research Off | M - OptEx | $21.40 | +191.5K | 211.0K | +980% | +$4.10M |
| DMT | 2026-09-17 21:35 | 2026-09-15+ | TVTX | ROTE WILLIAM E. | Chief Research Off | S - Sale+OE | $62.83 | -209.0K | 98.2K | -68% | -$13.14M |
| DMT | 2026-09-17 21:35 | 2026-09-15+ | TVTX | Heerma Peter | EVP, Chief COMMERCIAL Off | M - OptEx | $15.69 | +258.2K | 125.3K | New | +$4.05M |
| DMT | 2026-09-17 21:35 | 2026-09-15+ | TVTX | Heerma Peter | EVP, Chief COMMERCIAL Off | S - Sale+OE | $63.06 | -283.2K | 117.1K | -71% | -$17.86M |
| DT | 2026-09-17 21:33 | 2026-09-15 | TVTX | Inrig Jula | EVP, CMO, Head of R, D | M - OptEx | $8.93 | +32.4K | 145.2K | +29% | +$289.3K |
| DMT | 2026-09-17 21:33 | 2026-09-15 | TVTX | Inrig Jula | EVP, CMO, Head of R, D | S - Sale+OE | $62.34 | -44.7K | 100.5K | -31% | -$2.79M |
| DT | 2026-09-17 21:32 | 2026-09-15 | TVTX | REED ELIZABETH E | CLO, GC | M - OptEx | $15.46 | +37.5K | 142.9K | +36% | +$579.8K |
| DMT | 2026-09-17 21:32 | 2026-09-15 | TVTX | REED ELIZABETH E | CLO, GC | S - Sale+OE | $62.34 | -37.5K | 105.4K | -26% | -$2.34M |
| DMT | 2026-09-17 21:31 | 2026-09-15+ | TVTX | Dube Eric M | CEO, Dir | M - OptEx | $23.34 | +400.0K | 541.4K | +283% | +$9.34M |
| DMT | 2026-09-17 21:31 | 2026-09-15+ | TVTX | Dube Eric M | CEO, Dir | S - Sale+OE | $63.48 | -400.0K | 432.9K | -48% | -$25.39M |
| DT | 2026-09-17 21:30 | 2026-09-15 | TVTX | Cline Christopher R. | CFO | M - OptEx | $17.44 | +20.0K | 138.0K | +17% | +$348.8K |
| DMT | 2026-09-17 21:30 | 2026-09-15 | TVTX | Cline Christopher R. | CFO | S - Sale+OE | $62.34 | -50.5K | 87.5K | -37% | -$3.15M |
| DMT | 2026-09-17 21:29 | 2026-09-15 | TVTX | Calvin Sandra | SVP, CAO | M - OptEx | $24.19 | +5,375 | 47.7K | +13% | +$130.0K |
| DMT | 2026-09-17 21:29 | 2026-09-15 | TVTX | Calvin Sandra | SVP, CAO | S - Sale+OE | $62.33 | -5,375 | 42.4K | -11% | -$335.0K |
| DMT | 2026-09-11 16:05 | 2026-09-10 | TVTX | Meckler Jeffrey A | Dir | M - OptEx | $21.98 | +20.0K | 111.5K | +22% | +$439.6K |
| DMT | 2026-09-11 16:05 | 2026-09-10 | TVTX | Meckler Jeffrey A | Dir | S - Sale+OE | $67.31 | -20.0K | 91.5K | -18% | -$1.35M |
| 2026-09-03 16:05 | 2026-09-02 | TVTX | Cline Christopher R. | CFO | S - Sale | $66.37 | -642 | 118.0K | -0.5% | -$42.6K | |
| DMT | 2026-08-19 16:05 | 2026-08-17+ | TVTX | LYONS GARY A | Dir | M - OptEx | $17.44 | +10.0K | 66.5K | +18% | +$174.4K |
| DMT | 2026-08-19 16:05 | 2026-08-17+ | TVTX | LYONS GARY A | Dir | S - Sale+OE | $63.28 | -10.0K | 61.5K | -14% | -$632.8K |
| 2026-06-22 16:37 | 2026-06-22 | TVTX | Inrig Jula | Chief MEDICAL Off | G - Gift | $0.00 | -468 | 112.8K | -0.4% | $0 | |
| DT | 2026-06-16 16:46 | 2026-06-12 | TVTX | Coughlin Timothy | Dir | M - OptEx | $26.52 | +10.0K | 66.2K | +18% | +$265.2K |
| DT | 2026-06-16 16:46 | 2026-06-12 | TVTX | Coughlin Timothy | Dir | S - Sale+OE | $50.07 | -10.0K | 56.2K | -15% | -$500.7K |
| DT | 2026-06-16 16:42 | 2026-06-12 | TVTX | Baynes Roy D. | Dir | M - OptEx | $21.38 | +4,500 | 46.0K | +11% | +$96.2K |
| DT | 2026-06-16 16:42 | 2026-06-12 | TVTX | Baynes Roy D. | Dir | S - Sale+OE | $50.00 | -4,500 | 41.5K | -10% | -$225.0K |
| D | 2026-05-21 17:00 | 2026-05-19 | TVTX | Williams Brinkley Ruth | Dir | A - Grant | $0.00 | +4,000 | 29.8K | +16% | $0 |
| D | 2026-05-21 17:00 | 2026-05-19 | TVTX | Squarer Ron | Dir | A - Grant | $0.00 | +4,000 | 39.4K | +11% | $0 |
| D | 2026-05-21 17:00 | 2026-05-19 | TVTX | Poole Sandra | Dir | A - Grant | $0.00 | +4,000 | 34.0K | +13% | $0 |
| D | 2026-05-21 17:00 | 2026-05-19 | TVTX | Orwin John A | Dir | A - Grant | $0.00 | +4,000 | 39.4K | +11% | $0 |
| D | 2026-05-21 17:00 | 2026-05-19 | TVTX | Meckler Jeffrey A | Dir | A - Grant | $0.00 | +4,000 | 91.5K | +5% | $0 |
| D | 2026-05-21 17:00 | 2026-05-19 | TVTX | LYONS GARY A | Dir | A - Grant | $0.00 | +4,000 | 61.5K | +7% | $0 |
| D | 2026-05-21 17:00 | 2026-05-19 | TVTX | Coughlin Timothy | Dir | A - Grant | $0.00 | +4,000 | 56.2K | +8% | $0 |
| D | 2026-05-21 17:00 | 2026-05-19 | TVTX | Bruhn Suzanne Louise | Dir | A - Grant | $0.00 | +4,000 | 32.8K | +14% | $0 |
| D | 2026-05-21 17:00 | 2026-05-19 | TVTX | Baynes Roy D. | Dir | A - Grant | $0.00 | +4,000 | 41.5K | +11% | $0 |
| T | 2026-05-19 16:05 | 2026-05-15 | TVTX | Coughlin Timothy | Dir | S - Sale | $43.49 | -3,250 | 52.2K | -6% | -$141.3K |
| DT | 2026-05-06 20:00 | 2026-05-05 | TVTX | Baynes Roy D. | Dir | M - OptEx | $18.27 | +4,500 | 42.0K | +12% | +$82.2K |
| DT | 2026-05-06 20:00 | 2026-05-05 | TVTX | Baynes Roy D. | Dir | S - Sale+OE | $46.65 | -4,500 | 37.5K | -11% | -$209.9K |
| DT | 2026-05-06 20:00 | 2026-05-04 | TVTX | Meckler Jeffrey A | Dir | M - OptEx | $16.33 | +8,000 | 95.5K | +9% | +$130.6K |
| DT | 2026-05-06 20:00 | 2026-05-04 | TVTX | Meckler Jeffrey A | Dir | S - Sale+OE | $45.00 | -8,000 | 87.5K | -8% | -$360.0K |
| DT | 2026-05-06 20:00 | 2026-05-04 | TVTX | ROTE WILLIAM E. | Chief Research Off | M - OptEx | $0.00 | +4,250 | 118.2K | +4% | $0 |
| DT | 2026-05-06 20:00 | 2026-05-06 | TVTX | ROTE WILLIAM E. | Chief Research Off | S - Sale+OE | $43.95 | -2,763 | 115.5K | -2% | -$121.4K |
| DMT | 2026-05-06 20:00 | 2026-05-04 | TVTX | REED ELIZABETH E | CLO, GC | M - OptEx | $14.81 | +24.2K | 109.5K | +28% | +$359.2K |
| DMT | 2026-05-06 20:00 | 2026-05-04+ | TVTX | REED ELIZABETH E | CLO, GC | S - Sale+OE | $45.06 | -24.2K | 105.2K | -19% | -$1.09M |
| DMT | 2026-05-06 20:00 | 2026-05-04 | TVTX | Inrig Jula | Chief MEDICAL Off | M - OptEx | $18.47 | +24.2K | 115.7K | +27% | +$448.0K |
| DMT | 2026-05-06 20:00 | 2026-05-04+ | TVTX | Inrig Jula | Chief MEDICAL Off | S - Sale+OE | $45.15 | -22.5K | 113.2K | -17% | -$1.02M |
| D | 2026-05-06 20:00 | 2026-05-04 | TVTX | Heerma Peter | Chief COMMERCIAL Off | M - OptEx | $0.00 | +4,250 | 142.9K | +3% | $0 |
| D | 2026-05-06 20:00 | 2026-05-05 | TVTX | Heerma Peter | Chief COMMERCIAL Off | S - Sale+OE | $46.65 | -2,174 | 140.7K | -2% | -$101.4K |
| DT | 2026-05-06 20:00 | 2026-05-04 | TVTX | Dube Eric M | CEO, Dir | M - OptEx | $0.00 | +22.5K | 455.4K | +5% | $0 |
| DT | 2026-05-06 20:00 | 2026-05-06 | TVTX | Dube Eric M | CEO, Dir | S - Sale+OE | $43.95 | -22.5K | 432.9K | -5% | -$988.9K |
| DT | 2026-05-06 20:00 | 2026-05-04 | TVTX | Cline Christopher R. | CFO | M - OptEx | $0.00 | +4,250 | 121.1K | +4% | $0 |
| DMT | 2026-05-06 20:00 | 2026-05-05+ | TVTX | Cline Christopher R. | CFO | S - Sale+OE | $46.31 | -2,491 | 118.7K | -2% | -$115.4K |
| DT | 2026-05-04 16:27 | 2026-05-01 | TVTX | Baynes Roy D. | Dir | M - OptEx | $6.82 | +9,750 | 47.2K | +26% | +$66.5K |
| DT | 2026-05-04 16:27 | 2026-05-01 | TVTX | Baynes Roy D. | Dir | S - Sale+OE | $44.22 | -9,750 | 37.5K | -21% | -$431.1K |
| T | 2026-04-23 16:05 | 2026-04-22 | TVTX | ROTE WILLIAM E. | Chief Research Off | S - Sale | $39.09 | -9,100 | 114.0K | -7% | -$355.7K |
| DT | 2026-04-16 16:05 | 2026-04-14 | TVTX | LYONS GARY A | Dir | M - OptEx | $16.33 | +8,000 | 65.5K | +14% | +$130.6K |
| DT | 2026-04-16 16:05 | 2026-04-14 | TVTX | LYONS GARY A | Dir | S - Sale+OE | $41.07 | -8,000 | 57.5K | -12% | -$328.6K |
| DMT | 2026-04-16 16:05 | 2026-04-14 | TVTX | Baynes Roy D. | Dir | M - OptEx | $17.60 | +32.8K | 70.2K | +87% | +$576.3K |
| DMT | 2026-04-16 16:05 | 2026-04-14 | TVTX | Baynes Roy D. | Dir | S - Sale+OE | $41.29 | -32.8K | 37.5K | -47% | -$1.35M |
| DMT | 2026-04-16 16:05 | 2026-04-14 | TVTX | Calvin Sandra | SVP, CAO | M - OptEx | $16.05 | +15.2K | 64.3K | +31% | +$244.8K |
| DT | 2026-04-16 16:05 | 2026-04-14 | TVTX | Calvin Sandra | SVP, CAO | S - Sale+OE | $41.07 | -22.0K | 42.4K | -34% | -$902.6K |
| 2026-04-15 21:49 | 2026-04-13 | TVTX | Heerma Peter | Chief COMMERCIAL Off | A - Grant | $0.00 | +14.0K | 145.8K | +11% | $0 | |
| 2026-04-15 21:49 | 2026-04-14 | TVTX | Heerma Peter | Chief COMMERCIAL Off | S - Sale | $41.93 | -7,215 | 138.6K | -5% | -$302.5K | |
| T | 2026-04-15 21:48 | 2026-04-13 | TVTX | ROTE WILLIAM E. | Chief Research Off | A - Grant | $0.00 | +14.0K | 123.1K | +13% | $0 |
| T | 2026-04-15 21:48 | 2026-04-13 | TVTX | Dube Eric M | CEO, Dir | A - Grant | $0.00 | +64.0K | 496.9K | +15% | $0 |
| MT | 2026-04-15 21:48 | 2026-04-15 | TVTX | Dube Eric M | CEO, Dir | S - Sale | $41.09 | -64.0K | 432.9K | -13% | -$2.63M |
| DT | 2026-04-15 21:47 | 2026-04-13 | TVTX | REED ELIZABETH E | CLO, GC | A - Grant | $0.00 | +14.0K | 119.2K | +13% | $0 |
| DMT | 2026-04-15 21:47 | 2026-04-14 | TVTX | REED ELIZABETH E | CLO, GC | M - OptEx | $17.76 | +37.5K | 156.7K | +31% | +$666.0K |
| DMT | 2026-04-15 21:47 | 2026-04-14+ | TVTX | REED ELIZABETH E | CLO, GC | S - Sale+OE | $41.29 | -51.5K | 105.2K | -33% | -$2.13M |
| T | 2026-04-15 21:46 | 2026-04-13 | TVTX | Cline Christopher R. | CFO | A - Grant | $0.00 | +14.0K | 125.2K | +13% | $0 |
| MT | 2026-04-15 21:46 | 2026-04-13+ | TVTX | Cline Christopher R. | CFO | S - Sale | $41.91 | -8,327 | 116.9K | -7% | -$349.0K |
| T | 2026-04-15 21:46 | 2026-04-13 | TVTX | Inrig Jula | Chief MEDICAL Off | A - Grant | $0.00 | +14.0K | 119.7K | +13% | $0 |
| MT | 2026-04-15 21:46 | 2026-04-14+ | TVTX | Inrig Jula | Chief MEDICAL Off | S - Sale | $42.01 | -8,233 | 111.5K | -7% | -$345.9K |
| DT | 2026-04-07 18:17 | 2026-04-06 | TVTX | Baynes Roy D. | Dir | M - OptEx | $26.52 | +10.0K | 47.5K | +27% | +$265.2K |
| DT | 2026-04-07 18:17 | 2026-04-06 | TVTX | Baynes Roy D. | Dir | S - Sale+OE | $33.00 | -10.0K | 37.5K | -21% | -$330.0K |
| DT | 2026-04-02 17:55 | 2026-04-01 | TVTX | Dube Eric M | CEO, Dir | M - OptEx | $15.46 | +60.0K | 492.9K | +14% | +$927.6K |
| DMT | 2026-04-02 17:55 | 2026-04-01 | TVTX | Dube Eric M | CEO, Dir | S - Sale+OE | $30.93 | -60.0K | 432.9K | -12% | -$1.86M |
| DT | 2026-04-02 17:55 | 2026-04-01 | TVTX | REED ELIZABETH E | CLO, GC | M - OptEx | $15.46 | +10.0K | 115.2K | +10% | +$154.6K |
| DT | 2026-04-02 17:55 | 2026-04-01 | TVTX | REED ELIZABETH E | CLO, GC | S - Sale+OE | $30.00 | -10.0K | 105.2K | -9% | -$300.0K |
| D | 2026-03-18 | 2026-03-16 | TVTX | REED ELIZABETH E | CLO, GC | M - OptEx | $19.08 | +10.0K | 115.2K | +10% | +$190.8K |
| D | 2026-03-18 | 2026-03-16 | TVTX | REED ELIZABETH E | CLO, GC | S - Sale+OE | $28.09 | -10.0K | 105.2K | -9% | -$280.9K |
| D | 2026-02-24 | 2026-02-20 | TVTX | Dube Eric M | CEO, Dir | M - OptEx | $15.46 | +60.0K | 492.9K | +14% | +$927.6K |
| D | 2026-02-24 | 2026-02-20 | TVTX | Dube Eric M | CEO, Dir | S - Sale+OE | $30.10 | -60.0K | 432.9K | -12% | -$1.81M |
| DM | 2026-02-19 | 2026-02-17 | TVTX | REED ELIZABETH E | CLO, GC | S - Sale+OE | $27.83 | -10.0K | 109.5K | -8% | -$278.3K |
| D | 2026-02-19 | 2026-02-17 | TVTX | REED ELIZABETH E | CLO, GC | M - OptEx | $19.08 | +10.0K | 115.2K | +10% | +$190.8K |
| M | 2026-02-05 | 2026-02-04 | TVTX | REED ELIZABETH E | CLO, GC | S - Sale | $32.18 | -2,994 | 105.7K | -3% | -$96.4K |
| M | 2026-02-05 | 2026-02-04 | TVTX | Cline Christopher R. | CFO | S - Sale | $32.19 | -1,745 | 111.3K | -2% | -$56.2K |
| M | 2026-02-05 | 2026-02-04 | TVTX | Inrig Jula | Chief MEDICAL Off | S - Sale | $32.21 | -1,779 | 105.9K | -2% | -$57.3K |
| D | 2026-02-03 | 2026-01-31 | TVTX | ROTE WILLIAM E. | Chief Research Off | A - Grant | $0.00 | +20.1K | 121.5K | +20% | $0 |
| D | 2026-02-03 | 2026-02-03 | TVTX | ROTE WILLIAM E. | Chief Research Off | S - Sale | $32.87 | -12.4K | 109.1K | -10% | -$409.1K |
| D | 2026-02-03 | 2026-01-31 | TVTX | Calvin Sandra | SVP, CAO | A - Grant | $0.00 | +15.2K | 53.4K | +40% | $0 |
| D | 2026-02-03 | 2026-02-03 | TVTX | Calvin Sandra | SVP, CAO | S - Sale | $32.12 | -4,333 | 49.1K | -8% | -$139.2K |
| D | 2026-02-03 | 2026-01-31 | TVTX | Cline Christopher R. | CFO | A - Grant | $0.00 | +28.1K | 120.2K | +31% | $0 |
| D | 2026-02-03 | 2026-02-03 | TVTX | Cline Christopher R. | CFO | S - Sale | $32.12 | -7,242 | 113.0K | -6% | -$232.6K |
| D | 2026-02-03 | 2026-01-31 | TVTX | REED ELIZABETH E | CLO, GC | A - Grant | $0.00 | +25.1K | 115.4K | +28% | $0 |
| D | 2026-02-03 | 2026-02-03 | TVTX | REED ELIZABETH E | CLO, GC | S - Sale | $32.12 | -7,175 | 108.2K | -6% | -$230.5K |
| D | 2026-02-03 | 2026-02-03 | TVTX | Heerma Peter | Chief COMMERCIAL Off | S - Sale | $32.12 | -7,310 | 131.8K | -5% | -$234.8K |
| D | 2026-02-03 | 2026-01-31 | TVTX | Heerma Peter | Chief COMMERCIAL Off | A - Grant | $0.00 | +26.1K | 139.1K | +23% | $0 |
| DM | 2026-02-03 | 2026-02-03 | TVTX | Dube Eric M | CEO, Dir | S - Sale | $32.28 | -100.1K | 466.5K | -18% | -$3.23M |
| D | 2026-02-03 | 2026-01-31 | TVTX | Dube Eric M | CEO, Dir | A - Grant | $0.00 | +113.8K | 533.0K | +27% | $0 |
| D | 2026-02-03 | 2026-01-31 | TVTX | Inrig Jula | Chief MEDICAL Off | A - Grant | $0.00 | +28.1K | 114.4K | +33% | $0 |
| D | 2026-02-03 | 2026-02-03 | TVTX | Inrig Jula | Chief MEDICAL Off | S - Sale | $32.12 | -6,956 | 107.5K | -6% | -$223.4K |
Purchase Sale Sale after option exercise All abbreviations